3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow SAR125844: new trials by email Literature Review of SAR125844 trials Research Report on SAR125844
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification SAR125844 - Neoplasm Malignant | Phase 2 | Completed | Sanofi | 1 | 2015-11-01 | 2016-03-23 |
| Phase I, Dose Escalation of SAR125844 in Asian Solid Tumor Patients SAR125844 - Neoplasm Malignant | Phase 1 | Completed | Sanofi | 70 | 2012-09-01 | 2016-02-17 |
| Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors SAR125844 - Malignant Solid Tumors | Phase 1 | Completed | Sanofi | 72 | 2011-07-01 | 2016-04-13 |
Neoplasms (2)
Sanofi (3)
Belgium (1) · France (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · United States (1)
2014 (1)